...
机译:6分钟步行距离测试作为慢性阻塞性肺疾病的分层工具:COPD生物标志物资格认证联合会的见解
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts,Pulmonary Critical Care Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115;
Boehringer Ingelheim, Ingelheim, Germany,Department of Sports Medicine, University of Tuebingen, Tuebingen, Germany;
Temple University Medical Center, Philadelphia, Pennsylvania;
National Institute for Health Research Respiratory Biomedical Research Unit at the Royal Brompton and Harefield National Health Service Foundation Trust and Imperial College, London, United Kingdom;
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania;
Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California;
GlaxoSmithKline Research and Development, King of Prussia, Pennsylvania;
Evidera, Bethesda, Maryland;
COPD Foundation, Washington, District of Columbia;
Division of Pulmonary, Allergy, Sleep and Critical Care Medicine, University of Nebraska Medical Center, Omaha, Nebraska;
chronic obstructive pulmonary disease; 6-minute-walk distance; outcomes;
机译:改善慢性阻塞性肺疾病的护理过程:评估COPD的工具中的COPD评估测试(CAT)
机译:慢性阻塞性肺疾病(COPD)和哮喘管理新的基于功能性的健康识字测量工具的开发和预用
机译:COPD评估测试(CAT):评估慢性阻塞性肺疾病的化学战患者生活质量的简单工具
机译:用词嵌入法分析慢性阻塞性肺疾病(COPD)及其生物标志物的相关性
机译:提供伦理护理:心肺复苏术(CPR)用于终末期肺病(ESLD)患者的慢性阻塞性肺疾病(COPD)加重。
机译:6分钟步行距离测试可作为慢性阻塞性肺疾病分层工具。 COPD生物标志物鉴定协会的见解
机译:作为COpD分层工具的6分钟步行测试:来自COpD生物标志物资格联盟的见解